CAS NO: 331731-18-1
Batch Molecular FormulaC6428H9912N1694O1987S46
Batch Molecular Weight144190.3
StorageStore at RT
Batch Molecular Structure

Adalimumab is a medication that falls under the class of drugs known as tumor necrosis factor-alpha (TNF-alpha) inhibitors. It is primarily used to treat various autoimmune diseases and inflammatory conditions. Adalimumab works by targeting and inhibiting TNF-alpha, a protein involved in the body’s immune response. By doing so, it helps reduce inflammation and control the immune system’s overactivity. Here are some of the common uses of adalimumab:

  1. Rheumatoid Arthritis: Adalimumab is often prescribed to manage the symptoms and slow the progression of rheumatoid arthritis, a chronic autoimmune disease that causes joint inflammation, pain, and damage.
  2. Ankylosing Spondylitis: This medication is used in the treatment of ankylosing spondylitis, a type of arthritis that primarily affects the spine and can cause pain, stiffness, and reduced mobility.
  3. Psoriatic Arthritis: Adalimumab is used to treat psoriatic arthritis, a condition that combines symptoms of arthritis with psoriasis, a skin condition.
  4. Plaque Psoriasis: It is also prescribed for moderate to severe plaque psoriasis, a skin condition characterized by raised, red, and scaly patches.
  5. Crohn’s Disease: Adalimumab can be used to manage the symptoms of Crohn’s disease, an inflammatory bowel disease that affects the digestive tract.
  6. Ulcerative Colitis: In some cases, it may be used to treat ulcerative colitis, another inflammatory bowel disease that primarily affects the colon and rectum.
  7. Hidradenitis Suppurativa: Adalimumab is also used to treat hidradenitis suppurativa, a chronic skin condition characterized by painful lumps, abscesses, and tunnels beneath the skin.

The use of adalimumab should be under the supervision and guidance of a healthcare provider who specializes in the treatment of autoimmune diseases and inflammatory conditions. The medication can have side effects, including an increased risk of infections, so patients typically undergo regular monitoring and are evaluated for its safety and efficacy during treatment. It is an effective therapy for many individuals with these conditions, helping to reduce symptoms and improve their quality of life.


  • Rheumatoid arthritis
  • Psoriatic arthritis
  • Ankylosing spondylitis
  • Crohn’s disease
  • Ulcerative colitis
  • Plaque psoriasis
  • Hidradenitis suppurativa
  • Juvenile idiopathic arthritis